NORPROLAC 25 and 50 micrograms, tablet 3 tablets
Active ingredients: Quinagolide hydrochloride, Quinagolide
Commercialized according to BDPMDispensing in France: Prescription only
Tablet3 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NORPROLAC 25 et 50 microgrammes, comprimé
- Pharmaceutical form
- comprimé et comprimé
- Route of administration
- orale
- Presentation description
- 3 comprimés roses et 3 comprimés bleus sous plaquette(s) PVC PVDC aluminium
- Marketing authorisation holder
- FERRING (FRANCE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 27 Jun 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68713946CIP73386477CIP133400933864774Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE QUINAGOLIDEcomprimé bleu | 0,0546 mg · un comprimé | SA |
| QUINAGOLIDEcomprimé bleu | 0,0500 mg · un comprimé | FT |
| CHLORHYDRATE DE QUINAGOLIDEcomprimé rose | 0,0273 mg · un comprimé | SA |
| QUINAGOLIDEcomprimé rose | 0,0250 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.